Temporal trends in acute myocardial infarction 101 10. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in . in pharmacotherapy, comorbidities, and demographics in patients referred for mortality from acute myocardial infarction in England between 2002 and 2010: coronary angiography: what changed during a decade? Eur Heart J Cardiovasc linked national database study. BMJ 2012;344:d8059. Pharmacother 2015;1:157–165. 11. Rosamond WD, Chambless LE, Heiss G, Mosley TH, Coresh J, Whitsel E, 26. Bjo ¨ rck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A. Medication in rela- Wagenknecht L, Ni H, Folsom AR. Twenty-two–year trends in incidence of myo- . tion to ST-segment elevation myocardial infarction in patients with a first cardial infarction, coronary heart disease mortality, and case fatality in 4 US myocardial infarction: Swedish register of information and knowledge about Communities, 1987–2008. Circulation 2012;125:1848–1857. Swedish Heart Intensive Care Admissions (RIKS-HIA). Arch Intern Med 12. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in 2010;170:1375–1381. the incidence and outcomes of acute myocardial infarction. N Engl J Med . 27. Go AS, Iribarren C, Chandra M, Lathon PV, Fortmann SP, Quertermous T, 2010;362:2155–2165. Hlatky MA; Atherosclerotic Disease, Vascular Function and Genetic 13. Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC; ARIC Investigators. Epidemiology (ADVANCE) Study. Statin and beta-blocker therapy and the initial Declining severity of myocardial infarction from 1987 to 2002 the Atherosclerosis . presentation of coronary heart disease. Ann Intern Med 2006;144:229–238. Risk in Communities (ARIC) Study. Circulation 2009;119:503–514. 28. Spencer FA, Santopinto JJ, Gore JM, Goldberg RJ, Fox KAA, Moscucci M, White 14. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent K, Gurfinkel EP. Impact of aspirin on presentation and hospital outcomes in trends in the incidence, treatment, and outcomes of patients with STEMI and patients with acute coronary syndromes (The Global Registry of Acute NSTEMI. Am J Med 2011;124:40–47. . Coronary Events [GRACE]). Am J Cardiol 2002;90:1056–1061. 15. Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack 29. Gottlieb S, Kolker S, Shlomo N, Matetzky S, Leitersdorf E, Segev A, Goldenberg CV, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in present- I, Tzivoni D, Weisz G, Moriel M. Association between statin treatment and LDL- ing characteristics and hospital mortality among patients with ST elevation and . cholesterol levels on the rate of ST-elevation myocardial infarction among non-ST elevation myocardial infarction in the National Registry of Myocardial patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010. Infarction from 1990 to 2006. Am Heart J 2008;156:1026–1034. Int J Cardiol 2016;210:133–138. 16. Roger VL, Weston SA, Gerber Y, Killian JM, Dunlay SM, Jaffe AS, Bell MR, Kors J, 30. Tousoulis D, Psarros C, Demosthenous M, Patel R, Antoniades C, Stefanadis C. Yawn BP, Jacobsen SJ. Trends in incidence, severity, and outcome of hospitalized . Innate and adaptive inflammation as a therapeutic target in vascular disease: the myocardial infarction. Circulation 2010;121:863–869. emerging role of statins. J Am Coll Cardiol 2014;63:2491–2502. 17. Jennings SM, Bennett K, Lonergan M, Shelley E. Trends in hospitalisation for 31. Tousoulis D, Simopoulou C, Papageorgiou N, Oikonomou E, Hatzis G, Siasos G, acute myocardial infarction in Ireland, 1997–2008. Heart 2012;98:1285–1289. . Tsiamis E, Stefanadis C. Endothelial dysfunction in conduit arteries and in micro- 18. Freisinger E, Fuerstenberg T, Malyar NM, Wellmann J, Keil U, Breithardt G, circulation. Novel therapeutic approaches. Pharmacol Ther 2014;144:253–267. Reinecke H. German nationwide data on current trends and management of 32. da Silva AR, Fraga-Silva RA, Stergiopulos N, Montecucco F, Mach F. Update on acute myocardial infarction: discrepancies between trials and real-life. Eur Heart J the role of angiotensin in the pathophysiology of coronary atherothrombosis. 2014;35:979–988. . Eur J Clin Invest 2015;45:274–287. 19. Wong CX, Sun MT, Lau DH, Brooks AG, Sullivan T, Worthley MI, Roberts- 33. Segev A, Matetzky S, Danenberg H, Fefer P, Bubyr L, Zahger D, Roguin A, Thomson KC, Sanders P. Nationwide trends in the incidence of acute myocardial Gottlieb S, Kornowski R; ACSIS and ACSIS-PCI 2010 Investigators. infarction in Australia, 1993-2010. Am J Cardiol 2013;112:169–173. . Contemporary use and outcome of percutaneous coronary interventions in 20. Roffi M, Patrono C, Collet J-P, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger patients with acute coronary syndromes: insights from the 2010 ACSIS and MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, ACSIS-PCI surveys. EuroIntervention 2012;8:465–469. Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S, Baumgartner H, 34. Sabbag A, Matetzky S, Gottlieb S, Fefer P, Kohanov O, Atar S, Zahger D, Porter Gaemperli O, Achenbach S, Agewall S, Badimon L, Baigent C, Bueno H, Bugiardini . A, Koifman B, Goldenberg I, Segev A. Recent temporal trends in the presenta- R, Carerj S, Casselman F, Cuisset T, Erol C ¸, Fitzsimons D, Halle M, Hamm C, . tion, management, and outcome of women hospitalized with acute coronary syn- Hildick-Smith D, Huber K, Iliodromitis E, James S, Lewis BS, Lip GYH, Piepoli MF, dromes. Am J Med 2015;128:380–388. Richter D, Rosemann T, Sechtem U, Steg PG, Vrints C, Zamorano JL. 2015 ESC 35. Terkelsen CJ, Lassen JF, Nørgaard BL, Gerdes JC, Jensen T, Gøtzsche LB-H, Guidelines for the management of acute coronary syndromes in patients presenting . Nielsen TT, Andersen HR. Mortality rates in patients with ST-elevation vs. non- without persistent ST-segment elevation. Eur Heart J 2016;37:267–315. ST-elevation acute myocardial infarction: observations from an unselected 21. Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J cohort. Eur Heart J 2005;26:18–26. Public Health 2011;39:30–33. 36. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, 22. Abildstrøm SZ, Madsen M. The Danish heart register. Scand J Public Health . Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, 2011;39:46–49. Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS. A 23. Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of Comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial the diagnosis of acute myocardial infarction in routine statistics: a comparison of . infarction. N Engl J Med 2003;349:733–742. mortality and hospital discharge data with the Danish MONICA registry. J Clin 37. Schmidt M, Hallas J, Friis S. Potential of prescription registries to capture Epidemiol 2003;56:124–130. individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in 24. Kildemoes HW, Sørensen HT, Hallas J. The Danish national prescription registry. Denmark: trends in utilization 1999–2012. Clin Epidemiol 2014;6:155. Scand J Public Health 2011;39:38–41. . 38. Stein GY, Herscovici G, Korenfeld R, Matetzky S, Gottlieb S, Alon D, Gevrielov- 25. Jørgensen ME, Andersson C, Olsen A-MS, Juel K, Mortensen PE, Jørgensen E, Yusim N, Iakobishvili Z, Fuchs S, Guo Y. Type-II myocardial infarction—patient Tilsted H-H, Kappelgaard LM, von Torp-Pedersen C, Gislason GH. Danish trends characteristics, management and outcomes. PLoS One 2014;9:e84285. Erratum doi:10.1093/ehjcvp/pvw025 Online publish-ahead-of-print 20 October 2016 .................................................................................................................................................... Erratum to: SGLT1 does compensate for SGLT2 inhibition [Eur Heart J Cardiovasc Pharmacother (2016) 2 (4): 256] The reference to Figure 2, segments S1 and S3, of the article by de Leeuw et al. in the above correspondence paper was incorrectly cited as supplementary data. There is no supplementary data for this article and this has now been corrected online. The publisher apologizes for this error. Published on behalf of the European Society of Cardiology. All rights reserved. V The Author 2016. For Permissions, please email: email@example.com. Downloaded from https://academic.oup.com/ehjcvp/article-abstract/4/2/101/2433487 by Ed 'DeepDyve' Gillespie user on 16 March 2018
European Heart Journal - Cardiovascular Pharmacotherapy – Oxford University Press
Published: Apr 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera